Skip to main content
Premium Trial:

Request an Annual Quote

David Kratochvil

David Kratochvil has been appointed CFO and Treasurer of VolitionRx, effective Aug. 17. He will lead the firm's financial strategy as it prepares for the launch of the NuQ tests in the US and elsewhere. Ktratochvil replaces Mike O'Connell. 

Kratochvil joins VolitionRx from Euro Pacific Capital where he was managing director in the corporate finance department. Before that, he was at Omega Advisors and a director at Merrill Lynch Asset Management. He also founded his own advisory firm Vista Capital Advisors. 

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.